Executive record
Keith Regnante
Most recent record: Keros Therapeutics, Inc. names Annita Tanini interim CFO (named as the outgoing officer), effective August 4, 2026.
2 verified records · 1 company
Career line from the records
2Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-07-22InterimKeros Therapeutics, Inc.
Keros Therapeutics, Inc. names Annita Tanini interim CFONamed as the outgoing officer
effective August 4, 2026 · 8-K filed July 22, 2026 · sec.gov, Item 5.02
2026-03-0410-K signatureKeros Therapeutics, Inc.
Signed the annual report as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
10-K filed March 4, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Keith Regnante, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.